Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP613850.RAKN51o2YYptjdwQvPgK4gbM7a_sw9NA1lCMsW1dWdX_8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP613850.RAKN51o2YYptjdwQvPgK4gbM7a_sw9NA1lCMsW1dWdX_8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP613850.RAKN51o2YYptjdwQvPgK4gbM7a_sw9NA1lCMsW1dWdX_8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP613850.RAKN51o2YYptjdwQvPgK4gbM7a_sw9NA1lCMsW1dWdX_8130_provenance.
- NP613850.RAKN51o2YYptjdwQvPgK4gbM7a_sw9NA1lCMsW1dWdX_8130_assertion description "[epidermal growth factor receptor), along with the introduction of FDA approved pharmacogenetic tests (UGT1A1*28) and the initiation of a genotype-guided clinical trial for cancer therapy (TYMS TSER in rectal cancer) have provided the first steps towards the integration of pharmacogenomics into clinical practice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613850.RAKN51o2YYptjdwQvPgK4gbM7a_sw9NA1lCMsW1dWdX_8130_provenance.
- NP613850.RAKN51o2YYptjdwQvPgK4gbM7a_sw9NA1lCMsW1dWdX_8130_assertion evidence source_evidence_literature NP613850.RAKN51o2YYptjdwQvPgK4gbM7a_sw9NA1lCMsW1dWdX_8130_provenance.
- NP613850.RAKN51o2YYptjdwQvPgK4gbM7a_sw9NA1lCMsW1dWdX_8130_assertion SIO_000772 16651374 NP613850.RAKN51o2YYptjdwQvPgK4gbM7a_sw9NA1lCMsW1dWdX_8130_provenance.
- NP613850.RAKN51o2YYptjdwQvPgK4gbM7a_sw9NA1lCMsW1dWdX_8130_assertion wasDerivedFrom befree-20140225 NP613850.RAKN51o2YYptjdwQvPgK4gbM7a_sw9NA1lCMsW1dWdX_8130_provenance.
- NP613850.RAKN51o2YYptjdwQvPgK4gbM7a_sw9NA1lCMsW1dWdX_8130_assertion wasGeneratedBy ECO_0000203 NP613850.RAKN51o2YYptjdwQvPgK4gbM7a_sw9NA1lCMsW1dWdX_8130_provenance.
- befree-20140225 importedOn "2014-02-25" NP613850.RAKN51o2YYptjdwQvPgK4gbM7a_sw9NA1lCMsW1dWdX_8130_provenance.